Metronidazole Ratiopharm

Metronidazole, the active ingredient in Metronidazole Ratiopharm, is a Nitroimidazole antibiotic presented as an oral tablet for Oral use. It treats infections caused by anaerobic bacteria and certain protozoa in adults and children as prescribed by a healthcare professional.

GNH USA supplies Metronidazole Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is a nitroimidazole antibiotic used to treat infections caused by anaerobic bacteria and protozoa.

- Bacterial vaginosis: eradicates the anaerobic flora responsible for vaginal discharge and odor. - Trichomoniasis: eliminates Trichomonas vaginalis infection in the genital tract. - Amoebiasis: clears intestinal Entamoeba histolytica infection and related liver abscesses. - Anaerobic bacterial infections: treats intra‑abdominal, skin, and soft‑tissue infections caused by susceptible anaerobes. - Clostridioides difficile infection: reduces toxin‑producing C. difficile overgrowth in the colon.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: persistent metallic sensation in the mouth. - Headache: occasional throbbing head pain. - Diarrhea: loose stools during therapy. - Abdominal pain: cramping or discomfort. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Seizures: convulsive episodes, especially in high doses. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering. - Pseudomembranous colitis: inflammation of the colon. - Hepatotoxicity: liver enzyme elevation or injury.

Before prescribing Metronidazole, clinicians should consider several safety factors. - Pregnancy: consult a healthcare provider; safety data are limited. - Breastfeeding: may be excreted in milk; weigh benefits against potential risks. - Alcohol: avoid concurrent alcohol intake to prevent disulfiram‑like reactions. - Liver disease: use with caution; monitor hepatic function. - Renal impairment: adjust dose if severe kidney dysfunction is present. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Metronidazole can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: can potentiate anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma levels. - Phenobarbital: may decrease metronidazole concentrations. - Bupropion: may raise seizure risk when combined.